APPLIED MATERIALS INC /DE — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that APPLIED MATERIALS INC /DE filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Oct 27, 2019 | $3.75B | Dec 13, 2019 |
| FY2019 | Jul 28, 2019 | $3.56B | Dec 13, 2019 |
| FY2019 | Apr 28, 2019 | $3.54B | Dec 13, 2019 |
| FY2019 | Jan 27, 2019 | $3.75B | Dec 13, 2019 |
| FY2018 | Oct 28, 2018 | $4.01B | Dec 13, 2018 |
| FY2018 | Jul 29, 2018 | $4.47B | Dec 13, 2018 |
| FY2018 | Apr 29, 2018 | $4.57B | Dec 13, 2018 |
| FY2018 | Jan 28, 2018 | $4.20B | Dec 13, 2018 |
| FY2018 | Oct 29, 2017 | $3.97B | Dec 13, 2018 |
| FY2018 | Jul 30, 2017 | $3.74B | Dec 13, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 26, 2025 | $28.37B | Dec 12, 2025 |
| FY2025 | Oct 27, 2024 | $27.18B | Dec 12, 2025 |
| FY2025 | Oct 29, 2023 | $26.52B | Dec 12, 2025 |
| FY2024 | Oct 30, 2022 | $25.79B | Dec 13, 2024 |
| FY2023 | Oct 31, 2021 | $23.06B | Dec 15, 2023 |
| FY2020 | Oct 25, 2020 | $4.69B | Dec 11, 2020 |
| FY2020 | Jul 26, 2020 | $4.40B | Dec 11, 2020 |
| FY2020 | Apr 26, 2020 | $3.96B | Dec 11, 2020 |
| FY2020 | Jan 26, 2020 | $4.16B | Dec 11, 2020 |
| FY2020 | Oct 27, 2019 | $3.75B | Dec 11, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Oct 29, 2017 | $3.97B | Dec 15, 2017 |
| FY2017 | Jul 30, 2017 | $3.74B | Dec 15, 2017 |
| FY2017 | Apr 30, 2017 | $3.55B | Dec 15, 2017 |
| FY2017 | Jan 29, 2017 | $3.28B | Dec 15, 2017 |
| FY2017 | Oct 30, 2016 | $3.30B | Dec 15, 2017 |
| FY2017 | Jul 31, 2016 | $2.82B | Dec 15, 2017 |
| FY2017 | May 1, 2016 | $2.45B | Dec 15, 2017 |
| FY2017 | Jan 31, 2016 | $2.26B | Dec 15, 2017 |
| FY2016 | Oct 25, 2015 | $2.37B | Dec 15, 2016 |
| FY2016 | Jul 26, 2015 | $2.49B | Dec 15, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 26, 2025 | $13.81B | Dec 12, 2025 |
| FY2025 | Oct 27, 2024 | $12.90B | Dec 12, 2025 |
| FY2025 | Oct 29, 2023 | $12.38B | Dec 12, 2025 |
| FY2024 | Oct 30, 2022 | $11.99B | Dec 13, 2024 |
| FY2023 | Oct 31, 2021 | $10.91B | Dec 15, 2023 |
| FY2020 | Oct 25, 2020 | $2.13B | Dec 11, 2020 |
| FY2020 | Jul 26, 2020 | $1.96B | Dec 11, 2020 |
| FY2020 | Apr 26, 2020 | $1.75B | Dec 11, 2020 |
| FY2020 | Jan 26, 2020 | $1.86B | Dec 11, 2020 |
| FY2020 | Oct 27, 2019 | $1.63B | Dec 11, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 26, 2025 | $7.00B | Dec 12, 2025 |
| FY2025 | Oct 27, 2024 | $7.18B | Dec 12, 2025 |
| FY2025 | Oct 29, 2023 | $6.86B | Dec 12, 2025 |
| FY2024 | Oct 30, 2022 | $6.53B | Dec 13, 2024 |
| FY2023 | Oct 31, 2021 | $5.89B | Dec 15, 2023 |
| FY2020 | Oct 25, 2020 | $1.13B | Dec 11, 2020 |
| FY2020 | Jul 26, 2020 | $841.00M | Dec 11, 2020 |
| FY2020 | Apr 26, 2020 | $755.00M | Dec 11, 2020 |
| FY2020 | Jan 26, 2020 | $892.00M | Dec 11, 2020 |
| FY2020 | Oct 27, 2019 | $698.00M | Dec 11, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 26, 2025 | $8.29B | Dec 12, 2025 |
| FY2025 | Oct 27, 2024 | $7.87B | Dec 12, 2025 |
| FY2025 | Oct 29, 2023 | $7.65B | Dec 12, 2025 |
| FY2024 | Oct 30, 2022 | $7.79B | Dec 13, 2024 |
| FY2023 | Oct 31, 2021 | $6.89B | Dec 15, 2023 |
| FY2022 | Oct 25, 2020 | $4.37B | Dec 16, 2022 |
| FY2021 | Oct 27, 2019 | $3.35B | Dec 17, 2021 |
| FY2020 | Oct 28, 2018 | $4.49B | Dec 11, 2020 |
| FY2019 | Oct 29, 2017 | $3.94B | Dec 13, 2019 |
| FY2018 | Oct 30, 2016 | $2.15B | Dec 13, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 26, 2025 | $3.57B | Dec 12, 2025 |
| FY2025 | Oct 27, 2024 | $3.23B | Dec 12, 2025 |
| FY2025 | Oct 29, 2023 | $3.10B | Dec 12, 2025 |
| FY2024 | Oct 30, 2022 | $2.77B | Dec 13, 2024 |
| FY2023 | Oct 31, 2021 | $2.49B | Dec 15, 2023 |
| FY2022 | Oct 25, 2020 | $2.23B | Dec 16, 2022 |
| FY2021 | Oct 27, 2019 | $2.05B | Dec 17, 2021 |
| FY2020 | Oct 28, 2018 | $2.02B | Dec 11, 2020 |
| FY2019 | Oct 29, 2017 | $1.78B | Dec 13, 2019 |
| FY2018 | Oct 30, 2016 | $1.54B | Dec 13, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 26, 2025 | $1.77B | Dec 12, 2025 |
| FY2025 | Oct 27, 2024 | $1.80B | Dec 12, 2025 |
| FY2025 | Oct 29, 2023 | $1.63B | Dec 12, 2025 |
| FY2012 | Oct 28, 2012 | $1.08B | Dec 5, 2012 |
| FY2012 | Oct 30, 2011 | $901.00M | Dec 5, 2012 |
| FY2012 | Oct 31, 2010 | $942.00M | Dec 5, 2012 |
| FY2011 | Oct 25, 2009 | $735.00M | Dec 6, 2011 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 26, 2025 | $7.96B | Dec 12, 2025 |
| FY2025 | Oct 27, 2024 | $8.68B | Dec 12, 2025 |
| FY2025 | Oct 29, 2023 | $8.70B | Dec 12, 2025 |
| FY2024 | Oct 30, 2022 | $5.40B | Dec 13, 2024 |
| FY2023 | Oct 31, 2021 | $5.44B | Dec 15, 2023 |
| FY2022 | Oct 25, 2020 | $3.80B | Dec 16, 2022 |
| FY2021 | Oct 27, 2019 | $3.25B | Dec 17, 2021 |
| FY2020 | Oct 28, 2018 | $3.79B | Dec 11, 2020 |
| FY2019 | Oct 29, 2017 | $3.79B | Dec 13, 2019 |
| FY2018 | Oct 30, 2016 | $2.57B | Dec 13, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 26, 2025 | $2.26B | Dec 12, 2025 |
| FY2025 | Oct 27, 2024 | $1.19B | Dec 12, 2025 |
| FY2025 | Oct 29, 2023 | $1.11B | Dec 12, 2025 |
| FY2024 | Oct 30, 2022 | $787.00M | Dec 13, 2024 |
| FY2023 | Oct 31, 2021 | $668.00M | Dec 15, 2023 |
| FY2022 | Oct 25, 2020 | $422.00M | Dec 16, 2022 |
| FY2021 | Oct 27, 2019 | $441.00M | Dec 17, 2021 |
| FY2020 | Oct 28, 2018 | $622.00M | Dec 11, 2020 |
| FY2019 | Oct 29, 2017 | $345.00M | Dec 13, 2019 |
| FY2018 | Oct 30, 2016 | $253.00M | Dec 13, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 26, 2025 | $36.30B | Dec 12, 2025 |
| FY2025 | Oct 27, 2024 | $34.41B | Dec 12, 2025 |
| FY2024 | Oct 29, 2023 | $30.73B | Dec 13, 2024 |
| FY2023 | Oct 30, 2022 | $26.73B | Dec 15, 2023 |
| FY2022 | Oct 31, 2021 | $25.83B | Dec 16, 2022 |
| FY2021 | Oct 25, 2020 | $22.35B | Dec 17, 2021 |
| FY2020 | Oct 27, 2019 | $19.02B | Dec 11, 2020 |
| FY2019 | Oct 28, 2018 | $17.63B | Dec 13, 2019 |
| FY2018 | Oct 29, 2017 | $19.42B | Dec 13, 2018 |
| FY2017 | Oct 30, 2016 | $14.57B | Dec 15, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 26, 2025 | $15.88B | Dec 12, 2025 |
| FY2025 | Oct 27, 2024 | $15.41B | Dec 12, 2025 |
| FY2024 | Oct 29, 2023 | $14.38B | Dec 13, 2024 |
| FY2023 | Oct 30, 2022 | $14.53B | Dec 15, 2023 |
| FY2022 | Oct 31, 2021 | $13.58B | Dec 16, 2022 |
| FY2021 | Oct 25, 2020 | $11.78B | Dec 17, 2021 |
| FY2020 | Oct 27, 2019 | $10.81B | Dec 11, 2020 |
| FY2019 | Oct 28, 2018 | $10.79B | Dec 13, 2019 |
| FY2018 | Oct 29, 2017 | $10.07B | Dec 13, 2018 |
| FY2017 | Oct 30, 2016 | $7.35B | Dec 15, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 26, 2025 | $20.42B | Dec 12, 2025 |
| FY2025 | Oct 27, 2024 | $19.00B | Dec 12, 2025 |
| FY2025 | Oct 29, 2023 | $16.35B | Dec 12, 2025 |
| FY2025 | Oct 30, 2022 | $12.19B | Dec 12, 2025 |
| FY2024 | Oct 31, 2021 | $12.25B | Dec 13, 2024 |
| FY2023 | Oct 25, 2020 | $10.58B | Dec 15, 2023 |
| FY2022 | Oct 27, 2019 | $8.21B | Dec 16, 2022 |
| FY2021 | Oct 28, 2018 | $6.85B | Dec 17, 2021 |
| FY2020 | Oct 29, 2017 | $9.63B | Dec 11, 2020 |
| FY2019 | Oct 30, 2016 | $7.41B | Dec 13, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 26, 2025 | $3.71B | Dec 12, 2025 |
| FY2025 | Oct 27, 2024 | $3.73B | Dec 12, 2025 |
| FY2025 | Oct 29, 2023 | $3.73B | Dec 12, 2025 |
| FY2023 | Oct 30, 2022 | $3.70B | Dec 15, 2023 |
| FY2022 | Oct 31, 2021 | $3.48B | Dec 16, 2022 |
| FY2021 | Oct 25, 2020 | $3.47B | Dec 17, 2021 |
| FY2020 | Oct 27, 2019 | $3.40B | Dec 11, 2020 |
| FY2019 | Oct 28, 2018 | $3.37B | Dec 13, 2019 |
| FY2018 | Oct 29, 2017 | $3.37B | Dec 13, 2018 |
| FY2017 | Oct 30, 2016 | $3.32B | Dec 15, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 26, 2025 | $55.23B | Dec 12, 2025 |
| FY2025 | Oct 27, 2024 | $49.65B | Dec 12, 2025 |
| FY2024 | Oct 29, 2023 | $43.73B | Dec 13, 2024 |
| FY2023 | Oct 30, 2022 | $37.89B | Dec 15, 2023 |
| FY2022 | Oct 31, 2021 | $32.25B | Dec 16, 2022 |
| FY2021 | Oct 25, 2020 | $27.21B | Dec 17, 2021 |
| FY2020 | Oct 27, 2019 | $24.39B | Dec 11, 2020 |
| FY2019 | Oct 28, 2018 | $20.88B | Dec 13, 2019 |
| FY2018 | Oct 29, 2017 | $18.26B | Dec 13, 2018 |
| FY2017 | Oct 30, 2016 | $15.25B | Dec 15, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 26, 2025 | $7.24B | Dec 12, 2025 |
| FY2025 | Oct 27, 2024 | $8.02B | Dec 12, 2025 |
| FY2025 | Oct 29, 2023 | $6.13B | Dec 12, 2025 |
| FY2024 | Oct 30, 2022 | $2.00B | Dec 13, 2024 |
| FY2023 | Oct 31, 2021 | $5.00B | Dec 15, 2023 |
| FY2022 | Oct 25, 2020 | $5.35B | Dec 16, 2022 |
| FY2021 | Oct 27, 2019 | $3.13B | Dec 17, 2021 |
| FY2020 | Oct 28, 2018 | $3.44B | Dec 11, 2020 |
| FY2018 | Oct 29, 2017 | $5.01B | Dec 13, 2018 |
| FY2018 | Oct 30, 2016 | $3.41B | Dec 13, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Oct 25, 2020 | $5.45B | Dec 11, 2020 |
| FY2020 | Oct 27, 2019 | $5.31B | Dec 11, 2020 |
| FY2019 | Oct 28, 2018 | $5.31B | Dec 13, 2019 |
| FY2018 | Oct 29, 2017 | $5.30B | Dec 13, 2018 |
| FY2017 | Oct 30, 2016 | $3.13B | Dec 15, 2017 |
| FY2016 | Oct 25, 2015 | $3.34B | Dec 15, 2016 |
| FY2015 | Oct 26, 2014 | $1.95B | Dec 9, 2015 |
| FY2012 | Oct 28, 2012 | $1.90B | Dec 5, 2012 |
| FY2012 | Oct 30, 2011 | $1.90B | Dec 5, 2012 |
| FY2011 | Oct 31, 2010 | $206.00M | Dec 6, 2011 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 26, 2025 | 8 | Dec 12, 2025 |
| FY2025 | Oct 27, 2024 | 8 | Dec 12, 2025 |
| FY2025 | Oct 29, 2023 | 8 | Dec 12, 2025 |
| FY2024 | Oct 30, 2022 | 7 | Dec 13, 2024 |
| FY2023 | Oct 31, 2021 | 6 | Dec 15, 2023 |
| FY2022 | Oct 25, 2020 | 3 | Dec 16, 2022 |
| FY2021 | Oct 27, 2019 | 2 | Dec 17, 2021 |
| FY2020 | Oct 28, 2018 | 3 | Dec 11, 2020 |
| FY2019 | Oct 29, 2017 | 3 | Dec 13, 2019 |
| FY2018 | Oct 30, 2016 | 1 | Dec 13, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 26, 2025 | 8 | Dec 12, 2025 |
| FY2025 | Oct 27, 2024 | 8 | Dec 12, 2025 |
| FY2025 | Oct 29, 2023 | 8 | Dec 12, 2025 |
| FY2024 | Oct 30, 2022 | 7 | Dec 13, 2024 |
| FY2023 | Oct 31, 2021 | 6 | Dec 15, 2023 |
| FY2020 | Oct 25, 2020 | 1 | Dec 11, 2020 |
| FY2020 | Jul 26, 2020 | 0 | Dec 11, 2020 |
| FY2020 | Apr 26, 2020 | 0 | Dec 11, 2020 |
| FY2020 | Jan 26, 2020 | 0 | Dec 11, 2020 |
| FY2020 | Oct 27, 2019 | 0 | Dec 11, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 26, 2025 | 793.00M | Dec 12, 2025 |
| FY2025 | Oct 27, 2024 | 818.00M | Dec 12, 2025 |
| FY2024 | Oct 29, 2023 | 833.00M | Dec 13, 2024 |
| FY2023 | Oct 30, 2022 | 844.00M | Dec 15, 2023 |
| FY2022 | Oct 31, 2021 | 892.00M | Dec 16, 2022 |
| FY2021 | Oct 25, 2020 | 914.00M | Dec 17, 2021 |
| FY2020 | Oct 27, 2019 | 916.00M | Dec 11, 2020 |
| FY2019 | Oct 28, 2018 | 967.00M | Dec 13, 2019 |
| FY2018 | Oct 29, 2017 | 1.06B | Dec 13, 2018 |
| FY2017 | Oct 30, 2016 | 1.08B | Dec 15, 2017 |